tirzepatide news today Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots Tirzepatide outperformed semaglutide weight-loss drug

10.1016/j.cmet.2016.05.004 44 MllerT

Compounded semaglutide products can come in varying concentrations, and often are provided in multiple-use vials with potentially confusing dose instructions, the FDA said

EPH163 Off-label use of semaglutide in the United States: increasing prevalence, variability in prescribing provider specialty, and patient characteristics

In their separate trials, retatrutides top dose produced a higher average weight loss (28.3%) than Mounjaros (22.5% in SURMOUNT-1), a difference of roughly 6 percentage points

Tools like the GLP-1 plotter can help visualize your progress from the very first week

T., Kadowaki, T., Lingvay, I., Nauck, M., & Bain, S